Synthesis of DL-Hydroxybenzenamides as Anticonvulsants

Abstract

The anticonvulsant activity of some DL-hydroxybenzenamides is described. The following compounds from this series were prepared and tested: DL-2-hydroxy-2-(3’-bromophenyl)butyramide (4, CAS 620950-12-1), DL-2-hydroxy-2-(4’-bromophenyl)butyramide (5, CAS 620950-13-2), DL-2-hydroxy-2-(3’-nitrophenyl)butyramide (6, CAS 620950-14-3), DL-2-hydroxy-2-phenyl hexanamide (7, CAS 63002-05-1), DL-2-hydroxy-2-(3’,4’-dichlorophenyl)hexanamide (8, CAS 863976-06-1), DL-3-hydroxy-3-(4’-bromophenyl)pentanamide (9, CAS 620950-16-5), DL-3-hydroxy-3-phenylheptanamide (10, CAS 863976-08-3) and DL-4-hydroxy-4-(4’-bromophenyl)hexanamide (11, CAS 620950-18-7). Compounds 4, 5, 9 and 11 exhibited significant activity in seizures induced by pentylenetetrazol. Incorporation of bromine in the phenyl ring increased their potency. Compounds 4, 5, 9 and 11 exhibited a similar anticonvulsant activity as the reference drug phenobarbital (CAS 50-06-6).

Key words

Anticonvulsants - Antiepileptics - DL-Hydroxybenzenamides, anticonvulsant activity, synthesis

• References

• 1 Meza-Toledo SE, Zenteno-García MT, Juárez-Carvajal E, Martínez-Muñoz D, Carvajal-Sandoval G. A new homologous series of anticonvulsants: phenyl alcohol amides. Syntheses and pharmacological evaluation. Arzneimittel-Forschung (Drug Research). 1990; 40 (II) 1289-1291
• 2 Solís H, Jurado JL, Fernández-Guardiola A. La acción de la butiramida sobre el desarrollo del kindling y el kindling amigdalino ya establecido en el gato. In: Velasco-Suárez M, Escobedo-Rios F, eds. Neurobiología, Symposium International. México: Progreso; 1979; p. 83-94
• 3 Solís H, Galindo-Morales JA, Bravo J, López E. Efecto de la DL-4-hidroxi, 4-etil, 4-fenil butiramida (HEPB) y de su homólogo propionamida (HEPP) sobre la excitabilidad neuronal. Arch Neurocien (Méx). 1996; 1: 99-103
• 4 Brailowsky S, Montiel T, Hernández E, Marescaux C, Vergnes M. Effects of 3-hydroxy, 3-ethyl, 3-phenylpropionamide (HEPP) on rat models of generalized and focal epilepsy. Epilepsy Res. 1992; 11: 167-172
• 5 Carvajal-Sandoval G, Juárez-Carvajal E, Cruz-Peinado C, Meza-Toledo SE. Synthesis and pharmacological evaluation of a new homologous series of (±)-p-fluoro-phenyl alcohol amide anticonvulsants. Arzneimittel-Forschung (Drug Research). 1998; 48 (I) 349-352
• 6 Meza-Toledo SE, luárez-Carvajal E, Carvajal-Sandoval G. Synthesis of a new homologous series of p-chlorophenyl alcohol amides, their anticonvulsant activity and their testing as potential GABA_B receptor antagonists. Arzneimittel-Forschung (Drug Research). 1998; 48 (II:) 797-801
• 7 Meza-Toledo SE, Olea Gómez A, Mora-Ramirez EY, Peralta-Cruz J, Noguerón-Chirinos JB. Synthesis and pharmacological evaluation of some DL-dichlorophenyl alcohol amides anticonvulsants. Arzneimittel-Forschung (Drug Research). 2004; 54: 830-834
• 8 Peralta-Cruz J, Meza-Toledo SE. Complete assignment of the 1H, 13C, 15N and 19F NMR spectra of nine DL-phenyl alcoholamides anticonvulsants. Magn Reson Chem. 2004; 42: 81-82
• 9 Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949; 96: 99-113
• 10 Chamorro G, Salazar M, Salazar S, Chamorro G. Evaluation of the toxic and teratogenic potential of the anticonvulsant drug 4-hydroxy, 4-ethyl, 4-phenylbutyramide in mice. Arch Med Res. (Méx). 1994; 25: 441-446
• 11 Meza-Toledo SE, Ortega-González C, Juárez-Carvajal E, Carvajal-Sandoval G. Stereoselective anticonvulsant activity of the enantiomers of (±)– 2-hydroxy-2-phenylbutyramide. Arzneimittel-Forschung (Drug Research). 1995; 45 (II) 756-759
• 12 Pérez Mde la Mora, Tapia R. Anticonvulsant effect of 5-ethyl, 5-phenyl, 2-pyrrolidinone and its possible relationship to γ-aminobutyric acid-dependent inhibitory mechanisms. Biochem Pharmacol. 1973; 22: 2635-2639
• 13 Tapia R, Drucker-Colín RR, Meza-Ruiz G, Durán L, Levi G. Neurophysiological and neurochemical studies on the action of the anticonvulsant γ-hydroxy, γ-ethyl, γ-phenyl butyramide. Epilepsia. 1979; 20: 135-145
• 14 Meza-Toledo SE, Bowery NG. Reversal of GABA-mediated inhibition of the electrically and potassium chloride evoked [³H]-GABA release from rat substantia nigra slices by DL-3-hydroxy-3-phenyl pentanamide. Arzneimittel-Forschung (Drug Research). 2008; 58 (2) 53-61
• 15 Chávez JL, Martínez MD. Mecanismo de acción del anticonvulsionante DL-3-hidroxi, 3-etil, 3-fenil propionamida (HEPP). Arch Neurocien (Mex). 1996; 1: 173-177